Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Gynecology

Taking Control: Non-Surgical Vaginal Dilation

At a Glance

Non-surgical vaginal dilation is the recommended first-line treatment for creating a vaginal canal in MRKH patients. Using graduated dilators daily, patients can achieve success in 4 to 22 months. Emotional readiness and patient control are the most critical factors for successful treatment.

When you are ready to address the physical aspects of MRKH, the first and most recommended step is non-surgical vaginal dilation [1]. Major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), recommend this as the “first-line” treatment because it is highly effective and avoids the risks of surgery [2][3].

Dilation is not “fixing” something that is broken; rather, it is a process of using the body’s natural ability to expand skin and tissue over time [1]. It has a success rate of 90% to 96% when performed by patients who feel emotionally prepared [2][4].

The Dilation Process

There are two primary ways to perform dilation, both of which use graduated dilators (smooth, specialized tools that come in various sizes):

  • The Frank Method: This is a manual technique where you hold a dilator against the vaginal “dimple” (the area where the vaginal opening would be) and apply firm, steady pressure for a set amount of time [5].
  • The Ingram Method: This is a more passive technique where you sit on a specialized stool or “bicycle seat” device that holds the dilator in place, using your own body weight to apply pressure [5].

A typical routine involves dilating once or twice a day for about 10 to 20 minutes [6][7]. You start with the smallest size—about the width of a pinky finger—and only move up to the next size when the current one feels comfortable and slides in easily [6].

Managing Discomfort and Understanding Pain

One of the most common concerns is whether dilation will hurt. It is normal to feel a deep stretching sensation or mild discomfort, similar to stretching a muscle [1]. However, sharp or severe pain is not normal and means you should pause [7].

Pushing through intense pain can cause micro-tears in the tissue and make your pelvic floor muscles reflexively tighten, making future sessions harder [8]. Using plenty of high-quality, water-based lubricant and taking deep, relaxing breaths can significantly reduce discomfort [9]. Working with a pelvic floor physical therapist can provide strategies for relaxing these muscles.

Timeline and Milestones

Patience is the most important part of this process. Creating a functional vaginal canal (usually defined as being at least 6 cm deep) can take anywhere from 4 to 22 months [3][10]. Factors that influence the timeline include:

  • Consistency: Following your routine regularly is more important than how much pressure you use [7].
  • Tissue Elasticity: Everyone’s skin and tissue respond to pressure at different speeds [8].

Why You Are in Control

The single most important factor for success is psychological readiness [11][12]. Research shows that when patients are pushed into dilation before they are emotionally ready, they are much more likely to stop treatment or find the experience distressing [13][14].

You should only start dilation when you feel motivated and ready—not because a doctor or parent thinks it’s time [11]. This is a process that you own and control completely. You decide when to start, how fast to go, and when to take a break [15]. Many patients find it helpful to work with a specialized counselor who can help them navigate both the physical technique and the emotions that may come up [2][16].

Common questions in this guide

What is the best treatment for MRKH syndrome?
Non-surgical vaginal dilation is the highly recommended first-line treatment for MRKH. It boasts a 90% to 96% success rate for patients who are emotionally prepared and avoids the risks associated with surgery.
What is the difference between the Frank and Ingram dilation methods?
The Frank method is a manual technique where you hold a dilator against the vaginal dimple to apply steady pressure. The Ingram method uses a specialized bicycle-like seat to hold the dilator, using your own body weight to apply pressure passively.
Is vaginal dilation painful?
It is normal to feel a deep stretching sensation or mild discomfort, similar to stretching a muscle. However, sharp or severe pain is not normal and indicates that you should pause to prevent micro-tears or pelvic floor muscle tightening.
How long does it take for vaginal dilation to work?
Creating a functional vaginal canal typically takes anywhere from 4 to 22 months. Your specific timeline depends on your consistency with your daily routine and your body's natural tissue elasticity.
When is the right time to start vaginal dilation for MRKH?
You should only begin dilation when you feel personally motivated and emotionally ready, not because a doctor or parent pressures you. Psychological readiness is the single most important factor for a successful dilation process.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my anatomy, which dilation method (Frank or Ingram) would you recommend for me?
  2. 2.What milestones or 'success markers' should we look for to know the tissue is responding correctly?
  3. 3.If I feel pain or discomfort during dilation, what are the best techniques for troubleshooting?
  4. 4.Is there a pelvic floor physical therapist you recommend who specializes in MRKH?
  5. 5.If I start dilation and realize I'm not ready to continue, what is the process for pausing and restarting later?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Sexual function and quality of life after the creation of a neovagina in women with Mayer-Rokitansky-Küster-Hauser syndrome: comparison of vaginal dilation and surgical procedures.

    Kang J, Chen N, Song S, et al.

    Fertility and sterility 2020; (113(5)):1024-1031 doi:10.1016/j.fertnstert.2020.01.017.

    PMID: 32386614
  2. 2

    ACOG Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, And Treatment.

    Obstetrics and gynecology 2018; (131(1)):e35-e42 doi:10.1097/AOG.0000000000002458.

    PMID: 29266078
  3. 3

    Treatment of patients with Mayer-Rokitansky- Küster-Hauser syndrome in a tertiary hospital.

    Ng K, Ip PNP, Yiu KW, et al.

    Hong Kong medical journal = Xianggang yi xue za zhi 2020; (26(5)):397-403 doi:10.12809/hkmj208467.

    PMID: 33060366
  4. 4

    Three-dimensional Printer Molds for Vaginal Agenesis: An Individualized Approach as Conservative Treatment.

    Fernandes MS, Takano CC, Chrispin TTB, et al.

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2022; (44(12)):1110-1116 doi:10.1055/s-0042-1756214.

    PMID: 36138536
  5. 5

    Methods for neovagina creation in women with Mayer-Rokitansky-Küster-Hauser syndrome for subsequent uterus transplantation.

    Chmel R, Pastor Z, Novackova M, et al.

    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2021; (165(4)):360-366 doi:10.5507/bp.2021.049.

    PMID: 34446938
  6. 6

    Four cases of Mayer-Rokitansky-Küster-Hauser syndrome treated via non-surgical vaginal reconstruction using uterine cervical dilators.

    Kawasaki A, Itagagi H, Tsumagari A, et al.

    The journal of obstetrics and gynaecology research 2020; (46(3)):542-546 doi:10.1111/jog.14180.

    PMID: 31854484
  7. 7

    Vaginal dilator therapy for pelvic cancer patients: a review.

    Nair N, Brenner S, Rivera A, et al.

    Gynecologic oncology reports 2026; (66()):102140 doi:10.1016/j.gore.2026.102140.

    PMID: 42325809
  8. 8

    [Sexual functional outcomes of vaginal dilation therapy for MRKH syndrome: a prospective study].

    Duan JL, Chen N, Gao QQ, et al.

    Zhonghua fu chan ke za zhi 2024; (59(7)):540-547 doi:10.3760/cma.j.cn112141-20240318-00159.

    PMID: 39056131
  9. 9

    Primary vaginal dilation for vaginal agenesis: strategies to anticipate challenges and optimize outcomes.

    Oelschlager AM, Debiec K, Appelbaum H

    Current opinion in obstetrics & gynecology 2016; (28(5)):345-9 doi:10.1097/GCO.0000000000000302.

    PMID: 27454852
  10. 10

    Creation and maintenance of neo-vagina with the use of vaginal dilators as first line treatment: Results from a quaternary paediatric and adolescent gynaecology service in Australia.

    Wee A, Bagchi T, Kimble R

    The Australian & New Zealand journal of obstetrics & gynaecology 2022; (62(3)):439-444 doi:10.1111/ajo.13487.

    PMID: 35179224
  11. 11

    ACOG Committee Opinion No. 728 Summary: Müllerian Agenesis: Diagnosis, Management, And Treatment.

    Obstetrics and gynecology 2018; (131(1)):196-197 doi:10.1097/AOG.0000000000002452.

    PMID: 29266072
  12. 12

    Transverse Vaginal Septum Resection: Technique, Timing, and the Utility of Dilation. A Scoping Review of the Literature.

    Brander EPA, Vincent S, McQuillan SK

    Journal of pediatric and adolescent gynecology 2022; (35(1)):65-72 doi:10.1016/j.jpag.2021.09.002.

    PMID: 34517117
  13. 13

    Assessing the Experience of Vaginal Dilator Use and Potential Barriers to Ongoing Use among a Focus Group of Women with Mayer-Rokitansky-Küster-Hauser Syndrome.

    Adeyemi-Fowode OA, Dietrich JE

    Journal of pediatric and adolescent gynecology 2017; (30(4)):491-494 doi:10.1016/j.jpag.2017.02.002.

    PMID: 28216131
  14. 14

    The Sexuality of Adolescents and Young Women With MRKH Syndrome: A Qualitative Study.

    Tsitoura A, Michala L

    The journal of sexual medicine 2021; (18(12)):2012-2019 doi:10.1016/j.jsxm.2021.09.006.

    PMID: 34649813
  15. 15

    Feasibility of Nurse Practitioner Led Vaginal Dilation Therapy: A Retrospective Brief Report.

    Raffé-Devine J, Sachedina A, Ollivier R, et al.

    Journal of pediatric and adolescent gynecology 2026; (39(3)):445-448 doi:10.1016/j.jpag.2026.02.003.

    PMID: 41672233
  16. 16

    The need to integrate mental health treatment into the care of Mayer-Rokitansky-Küster-Hauser.

    Davoudian T, Hills E

    F&S reports 2025; (6(2)):116-119 doi:10.1016/j.xfre.2025.03.008.

    PMID: 40620385

This page is for educational purposes and provides information about non-surgical vaginal dilation. Always consult your gynecologist or pelvic floor physical therapist before beginning a new dilation routine.

Get notified when new evidence is published on Mayer-Rokitansky-Küster-Hauser syndrome type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.